GenMark Diagnostics, Inc. - FORM S-1/A - EX-23.2 - CONSENT OF DELOITTE & TOUCHE LLP (US) - April 20, 2010

Attached files

file filename
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - GenMark Diagnostics, Inc.ds1a.htm
EX-23.3 - CONSENT OF DELOITTE LLP (UK) - GenMark Diagnostics, Inc.dex233.htm
EX-10.4 - SECOND AMENDMENT AND TERMINATION OF COMMERCIAL LEASE AGREEMENT - GenMark Diagnostics, Inc.dex104.htm
EX-10.3 - FIRST AMENDMENT TO COMMERCIAL LEASE AGREEMENT - GenMark Diagnostics, Inc.dex103.htm
EX-99.1 - SCHEME OF ARRANGEMENT - GenMark Diagnostics, Inc.dex991.htm
EX-10.6 - AMENDMENT TO COMMERCIAL LEASE AGREEMENT - GenMark Diagnostics, Inc.dex106.htm
EX-10.5 - COMMERCIAL LEASE AGREEMENT - GenMark Diagnostics, Inc.dex105.htm
EX-10.26 - FIRST AMENDMENT TO MANUFACTURING SERVICES AGREEMENT - GenMark Diagnostics, Inc.dex1026.htm
EX-10.15 - 2010 EQUITY INCENTIVE PLAN - GenMark Diagnostics, Inc.dex1015.htm
EX-10.16 - FORM OF STOCK OPTION AGREEMENT - GenMark Diagnostics, Inc.dex1016.htm
EX-10.25 - MANUFACTURING SERVICES AGREEMENT - GenMark Diagnostics, Inc.dex1025.htm

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of our report dated March 18, 2010, relating to the financial statement of GenMark Diagnostics, Inc. (the “Company”) appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

San Diego, CA

April 20, 2010

GenMark Diagnostics, Inc. Reports